 |
|
|
|
|
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
Beth Frost-Johnson, Sr. VP of Marketing
Merge Healthcare
414.977.4254
bfrost@merge.com
|
|
Richard Linden, President and CEO
Merge Healthcare
414.977.4000
rlinden@merge.com
|
|
MERGE EMED TO SHOWCASE INNOVATIVE IMAGING SOLUTIONS AT THE AMERICAN COLLEGE OF RADIOLOGY NATIONAL CONFERENCE ON BREAST CANCER (NCBC)
Multi-slice modality review with I-ReadMammo™ delivers strong ROI
Milwaukee, WI, April 29, 2006 – Merge eMed, a Merge Healthcare company
(NASDAQ: MRGE; TSX: MRG) and a leading medical imaging software and services
company, today announced that it will showcase Cedara I-ReadMammo™ digital
mammography workstation software and Cedara B-CAD, a solution designed to assist
radiologists in the analysis of breast lesions using ultrasound images, at ACR's National
Conference on Breast Cancer, April 29 - 30, in San Diego, CA.
Cedara I-ReadMammo is a multi modality, vendor-neutral mammography workstation software solution, designed to help organizations streamline breast imaging workflow and reduce costs in adopting digital mammography. Another innovative solution that will be featured is Cedara B-CAD, which is uniquely positioned to reduce the quantity of time required by a radiologist to analyze and report the findings of breast ultrasound
images. This timesaving application provides tools for automatic image analysis,
segmentation, and classification.
"The value proposition for our customers is a short ROI, with even lower volume sites having a payback within one year," said Beth Frost-Johnson, Merge Healthcare Senior Vice-President, Marketing. "This is another example of ways in which Merge eMed works as a business partner with its customers, creating solutions that add to the financial and clinical health of their businesses. We are pleased to create and own our RIS/PACS and Clinical Applications that deliver solid ROI's for our customers."
Cedara I-ReadMammo and B-CAD will be shown in the Merge eMed booth, #512.
For additional information, visit Merge eMed's special mammography site at
www.ireadmammo.com, or to learn more about Merge eMed's RIS, PACS, RIS/PACS and
other clinical applications, go to www.merge-emed.com.
# # #
Merge Healthcare is a market leader in the development and delivery of medical imaging and
information management software and services. Our innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our enduser solutions improve our customers' productivity and enhance the quality of patient care they provide. For additional information, visit our website at www.merge.com.
Merge eMed, a Merge Healthcare company, is focused on accelerating productivity for radiology departments and specialty practices, imaging centers and hospitals. By combining sophisticated RIS, PACS, advanced visualization and clinical imaging applications, Merge eMed delivers integrated endto- end software solutions and professional services that are transforming the way our customers interact with referring physicians, manage their workflow, position their businesses in their markets and deliver imaging and information services to their customers. For additional information, visit our website at www.merge-emed.com.
Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words: guidance, believes, intends, anticipates, expects, and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those projected in the forward-looking statements based on a number of factors, including, but not limited to, risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, unexpected outcomes to any pending or future litigation, changing economic conditions, credit and payment risks associated with end user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect any future events or circumstances.
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
